
LSL Pharma receives Health Canada OK for six products
LSL Pharma receives Health Canada OK for six products

LSL Pharma receives Health Canada OK for six products
Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
HEALTH CANADA GRANTS LSL PHARMA GROUP APPROVAL TO COMMERCIALIZE SIX NEW STERILE OPHTHALMIC SOLUTIONS
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES
Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan
Aurora Spine launches Aurora Biologics
Unidoc Health closes $1.5-million offering
Onco-Innovations Announces Closing of Private Placement
Aurora Spine Launches New Biologics Portfolio
UniDoc Closes Fully Subscribed LIFE Offering
Neupath Health to release Q3 2025 results Nov. 13
NEUPATH HEALTH TO REPORT Q3 RESULTS AND HOST INVESTOR WEBINAR
Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference
Apolo V Acquisition Corp. Completes Initial Public Offering
DiagnosTear Technologies Inc. Announces Upsizing of Private Placement of Units